# 2026-01947: Importer of Controlled Substances Application: Mylan Inc.

2026-01947, Importer of Controlled Substances Application: Mylan Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-02-02, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 4, 2026. Such persons may also file a written request for a hearing on the application on or before March 4, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-01947
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-01947
- Title: Importer of Controlled Substances Application: Mylan Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 4634
- Published: 2026-02-02
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 4, 2026. Such persons may also file a written request for a hearing on the application on or before March 4, 2026.
- Comments close: 2026-03-04
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

Mylan Inc. wants to become an official importer of certain controlled drugs like amphetamines and methylphenidate. This means they’ll be allowed to bring these medicines into the U.S. Companies and people involved can share their thoughts or ask for a hearing by March 4, 2026. This move could impact drug supply chains and involves careful government review but no immediate costs for the public.

## Abstract

Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-01947 on federalregister.gov](https://www.federalregister.gov/documents/2026/02/02/2026-01947/importer-of-controlled-substances-application-mylan-inc)
- [2026-01947 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-02-02/pdf/2026-01947.pdf)

## Related
- [Previous: 2026-01946, Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthc…](https://policyrisk.com/federal-register/2026-01946)
- [Next: 2026-01949, Talcott Resolution Life Insurance Company, et al.](https://policyrisk.com/federal-register/2026-01949)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-01947 (as of 2026-06-08).
